Schima, Susan M <br/><br/>
Fibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acid.  [electronic resource] 

 -  Expert opinion on pharmacotherapy  Apr 2010 
 - 731-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7666 
<br/><br/><label>Standard No.: </label>10.1517/14656560903575639  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cardiovascular Diseases--etiology<br/>Cholesterol, LDL--blood<br/>Delayed-Action Preparations<br/>Drug Delivery Systems<br/>Dyslipidemias--complications<br/>Fenofibrate--adverse effects<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects<br/>Hypolipidemic Agents--adverse effects